Bluejay Diagnostics IncEigentümerstruktur
| Preis (2024-05-01) | 52W Hoch | 52W Tief |
| 0.536 USD | 11,14 USD | 0,39 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 2.688.450 | 0,02 | 0,02 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Bluejay Diagnostics Inc
Mitarbeiter 10
Handelsplatz NASDAQ
Ticker Symbol BJDX
IPO Datum 2021-11-10
Adresse 360 Massachusetts Avenue, Acton, MA, United States, 01720
Webseite https://www.bluejaydx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Indranil Dey | Principal Financial, Accounting & Executive Officer, President, CEO and Director |
| 2 | Dr. Jason Cook | Chief Technology Officer |
| 3 | Mr. Les DeLuca | Vice President of Operations |
| 4 | Eryn Graham | Marketing Manager |
| 5 | Mr. Kevin Vance | Chief Commercial Officer |
| 6 | Mark W. Feinberg | Chief Medical Advisor |
| 7 | Dr. Mark W. Feinberg M.D. | Chief Medical Advisor |
| 8 | Ryan McSeveney | Corporate Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Sabby Management LLC | 0,00% | 0,00 Mio. USD |
| 2 | Armistice Capital, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Tower Research Capital LLC | 0,00% | 0,00 Mio. USD |
| 4 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 5 | Advisor Group Holdings, Inc. | 0,00% | 0,00 Mio. USD |
| 6 | Wells Fargo & Co | 0,00% | 0,00 Mio. USD |
| 7 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 8 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 9 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 10 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | TWO SIGMA SECURITIES, LLC | 0,00% | 0,00 Mio. USD |
| 13 | HRT FINANCIAL LLC | 0,00% | 0,00 Mio. USD |